P Kelly Marcom

发表

The Use of Bayesian Hierarchical Models for Adaptive Randomization in Biomarker-Driven Phase II Studies

Joseph G Ibrahim, William T Barry, Charles M Perou, 2015, Journal of biopharmaceutical statistics.

Invasive breast cancer.

Richard Zellars, Andres Forero, David A Mankoff, 2011, Journal of the National Comprehensive Cancer Network : JNCCN.

Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015.

Kenneth Offit, Elizabeth Swisher, Seema Khan, 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

Gene Expression Profiles of Multiple Breast Cancer Phenotypes and Response to Neoadjuvant Chemotherapy

Andrea Bild, Mike West, Zeljko Vujaskovic, 2006, Clinical Cancer Research.

Breast Cancer, Version 4.2017, NCCN Clinical Practice Guidelines in Oncology.

Amy M. Sitapati, Amy Sitapati, Andres Forero, 2018, Journal of the National Comprehensive Cancer Network : JNCCN.

Randomized phase III trial of weekly compared with every-3-weeks paclitaxel for metastatic breast cancer, with trastuzumab for all HER-2 overexpressors and random assignment to trastuzumab or not in HER-2 nonoverexpressors: final results of Cancer and Leukemia Group B protocol 9840.

Lyndsay Harris, Donald Berry, Larry Norton, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Can algorithmically assessed MRI features predict which patients with a preoperative diagnosis of ductal carcinoma in situ are upstaged to invasive breast cancer?

Maciej A Mazurowski, Lars J. Grimm, Ashirbani Saha, 2017, Journal of magnetic resonance imaging : JMRI.

Breast cancer. Clinical practice guidelines in oncology.

Krystyna Kiel, Mohammad Jahanzeb, Ingrid A Mayer, 2009, Journal of the National Comprehensive Cancer Network : JNCCN.

Randomized phase III trial of capecitabine compared with bevacizumab plus capecitabine in patients with previously treated metastatic breast cancer.

P Kelly Marcom, H. Rugo, B. Overmoyer, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Anastasia Ivanova, Charles M Perou, Katherine A Hoadley, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Recurrence-free survival in breast cancer is associated with MRI tumor enhancement dynamics quantified using computer algorithms.

Maciej A Mazurowski, Lars J. Grimm, Sujata V Ghate, 2015, European journal of radiology.

Pre-counseling education materials for BRCA testing: does tailoring make a difference?

Celette Sugg Skinner, Barbara K Rimer, Brian Calingaert, 2002, Genetic testing.

NCCN Guidelines Insights: Breast Cancer, Version 3.2018.

Amy M. Sitapati, Amy Sitapati, Chau Dang, 2019, Journal of the National Comprehensive Cancer Network : JNCCN.

Breast Cancer Version 2.2015.

Andres Forero, Hatem Soliman, Rashmi Kumar, 2015, Journal of the National Comprehensive Cancer Network : JNCCN.